LIVE IN YOUR SKIN - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
85398658
Word Mark
LIVE IN YOUR SKIN
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2012-12-15
Filing Date
2011-08-16
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2012-01-17
Attorney Name
Law Office Assigned Location Code
M30
Employee Name
LEASER, ANDREW C
Statements
Goods and Services
Medical sheeting used for scar therapy
Classification Information
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2011-08-19
Primary Code
010
First Use Anywhere Date
2011-04-00
First Use In Commerce Date
2011-04-00
Correspondences
Name
DAVID D. KALISH
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2011-08-19 | NEW APPLICATION ENTERED IN TRAM |
2011-08-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2011-12-07 | ASSIGNED TO EXAMINER |
2011-12-07 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2011-12-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2012-01-17 | PUBLISHED FOR OPPOSITION |
2012-01-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2012-03-13 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2012-04-12 | TEAS STATEMENT OF USE RECEIVED |
2012-05-03 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2012-04-12 | USE AMENDMENT FILED |
2012-05-09 | STATEMENT OF USE PROCESSING COMPLETE |
2012-05-19 | SU - NON-FINAL ACTION - WRITTEN |
2012-05-19 | NON-FINAL ACTION E-MAILED |
2012-05-19 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2012-12-15 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2012-12-17 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |